HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression

Integration of human papillomavirus (HPV) genomes into cellular chromatin is common in HPV-associated cancers. Integration is random, and each site is unique depending on how and where the virus integrates. We recently showed that tandemly integrated HPV16 could result in the formation of a super-enhancer-like element that drives transcription of the viral oncogenes. Here, we characterize the chromatin landscape and genomic architecture of this integration locus to elucidate the mechanisms that promoted de novo super-enhancer formation. Using next-generation sequencing and molecular combing/fiber-FISH, we show that ~26 copies of HPV16 are integrated into an intergenic region of chromosome 2p23.2, interspersed with 25 kb of amplified, flanking cellular DNA. This interspersed, co-amplified viral-host pattern is frequent in HPV-associated cancers and here we designate it as Type III integration. An abundant viral-cellular fusion transcript encoding the viral E6/E7 oncogenes is expressed from the integration locus and the chromatin encompassing both the viral enhancer and a region in the adjacent amplified cellular sequences is strongly enriched in the super-enhancer markers H3K27ac and Brd4. Notably, the peak in the amplified cellular sequence corresponds to an epithelial-cell-type specific enhancer. Thus, HPV16 integration generated a super-enhancer-like element composed of tandem interspersed copies of the viral upstream regulatory region and a cellular enhancer, to drive high levels of oncogene expression.

[1]  K. Ersfeld.  Fiber-FISH: fluorescence in situ hybridization on stretched DNA. , 2004, Methods in molecular biology.

[2]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[3]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[4]  Timothy J. Durham,et al.  Systematic analysis of chromatin state dynamics in nine human cell types , 2011, Nature.

[5]  Geir Kjetil Sandve,et al.  Transcriptionally Active Regions Are the Preferred Targets for Chromosomal HPV Integration in Cervical Carcinogenesis , 2015, PloS one.

[6]  A. Services,et al.  Integrated genomic and molecular characterization of cervical cancer. , 2017 .

[7]  Chandra Sekhar Pedamallu,et al.  Characterization of HPV and host genome interactions in primary head and neck cancers , 2014, Proceedings of the National Academy of Sciences.

[8]  Alix Warburton,et al.  The role of integration in oncogenic progression of HPV-associated cancers , 2017, PLoS pathogens.

[9]  Nicolas Wentzensen,et al.  Carcinogenic human papillomavirus infection , 2016, Nature Reviews Disease Primers.

[10]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[11]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[12]  E. Flores,et al.  Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. , 1999, Virology.

[13]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[14]  H. Bernard,et al.  Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. , 2008, Virology.

[15]  M. von Knebel Doeberitz,et al.  Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. , 1999, Cancer research.

[16]  Shwu‐Yuan Wu,et al.  Brd4 Is Displaced from HPV Replication Factories as They Expand and Amplify Viral DNA , 2013, PLoS pathogens.

[17]  R. Mitra,et al.  The Papillomavirus E1 Helicase Activates a Cellular DNA Damage Response in Viral Replication Foci , 2011, Journal of Virology.

[18]  J. Lieb,et al.  What are super-enhancers? , 2014, Nature Genetics.

[19]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[20]  P. Farnham,et al.  Using ChIP-seq technology to generate high-resolution profiles of histone modifications. , 2011, Methods in molecular biology.

[21]  J. McDougall,et al.  Viral integration and fragile sites in human papillomavirus‐lmmortalized human keratinocyte cell lines , 1992, Genes, chromosomes & cancer.

[22]  S Povey,et al.  Dynamic molecular combing: stretching the whole human genome for high-resolution studies. , 1997, Science.

[23]  A. McBride,et al.  Papillomavirus Genomes Associate with BRD4 to Replicate at Fragile Sites in the Host Genome , 2014, PLoS pathogens.

[24]  B. Norrild,et al.  The 3' region of Human Papillomavirus type 16 early mRNAs decrease expression , 2005, BMC infectious diseases.

[25]  P. Lambert,et al.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Ustav,et al.  Genomic instability of the host cell induced by the human papillomavirus replication machinery , 2007, The EMBO journal.

[27]  Trevor J Pugh,et al.  Landscape of genomic alterations in cervical carcinomas , 2013, Nature.

[28]  M. Rajeevan,et al.  Universal Human Papillomavirus Typing Assay: Whole-Genome Sequencing following Target Enrichment , 2016, Journal of Clinical Microbiology.

[29]  A. Nicolas,et al.  Mechanistic signatures of HPV insertions in cervical carcinomas , 2016, npj Genomic Medicine.

[30]  L. Meisner,et al.  Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. , 2000, The Journal of investigative dermatology.

[31]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[32]  S. Wolf,et al.  Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas , 2013, PloS one.

[33]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[34]  Ira M. Hall,et al.  Genome-wide mapping and assembly of structural variant breakpoints in the mouse genome. , 2010, Genome research.

[35]  Karl Münger,et al.  Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteins , 2004, International journal of cancer.

[36]  J. Archambault,et al.  Nuclear Accumulation of the Papillomavirus E1 Helicase Blocks S-Phase Progression and Triggers an ATM-Dependent DNA Damage Response , 2011, Journal of Virology.

[37]  M. Ustav,et al.  Mechanism of Genomic Instability in Cells Infected with the High-Risk Human Papillomaviruses , 2009, PLoS pathogens.

[38]  Serban Nacu,et al.  Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..

[39]  John Herrick,et al.  Genomic organization of amplified MYC genes suggests distinct mechanisms of amplification in tumorigenesis. , 2005, Cancer research.

[40]  Alix Warburton,et al.  Tandemly Integrated HPV16 Can Form a Brd4-Dependent Super-Enhancer-Like Element That Drives Transcription of Viral Oncogenes , 2016, mBio.

[41]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[42]  W. Doerfler,et al.  Spreading of DNA methylation across integrated foreign (adenovirus type 12) genomes in mammalian cells , 1991, Journal of virology.

[43]  S. Vinokurova,et al.  Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions , 2002, Oncogene.

[44]  Nicolas Stransky,et al.  Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma , 2010, The Journal of pathology.

[45]  David I. Smith,et al.  Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma , 2003, Oncogene.

[46]  M. Machiela,et al.  Genomic characterization of viral integration sites in HPV‐related cancers , 2016, International journal of cancer.

[47]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[48]  M. Wagatsuma,et al.  Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences , 1990, Journal of virology.

[49]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[50]  Wolfgang Mayer,et al.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.

[51]  X. Fang,et al.  Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism , 2015, Nature Genetics.

[52]  T. Ried,et al.  Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability , 2014, Genome research.

[53]  P. Lambert,et al.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells , 1995, Journal of virology.

[54]  J. Kappes,et al.  Clonal Selection for Transcriptionally Active Viral Oncogenes during Progression to Cancer , 2004, Journal of Virology.

[55]  David I. Smith,et al.  Common fragile sites are preferential targets for HPV16 integrations in cervical tumors , 2003, Oncogene.